The levels of copeptin and the calcium-binding protein B (S-100B protein), which function as biomarkers for assessing stroke severity and predicting clinical outcomes, were significantly elevated in stroke patients compared to healthy controls (56). This evidence concerns the gene AVP and stroke disorder.